Decomposing the Energetic Impact of Drug Resistant Mutations in HIV-1 Protease on Binding DRV
- 4 March 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Theory and Computation
- Vol. 6 (4), 1358-1368
- https://doi.org/10.1021/ct9004678
Abstract
Darunavir (DRV) is a high affinity (4.5 × 10−12 M, ΔG = −15.2 kcal/mol) HIV-1 protease inhibitor. Two drug-resistant protease variants FLAP+ (L10I, G48V, I54V, V82A) and ACT (V82T, I84V) decrease the binding affinity with DRV by 1.0 and 1.6 kcal/mol, respectively. In this study, the absolute and relative binding free energies of DRV with wild-type protease, FLAP+, and ACT were calculated with MM-PB/GBSA and thermodynamic integration methods, respectively. Free energy decomposition elucidated that the mutations conferred resistance by distorting the active site of HIV-1 protease so that the residues that lost binding free energy were not limited to the sites of mutation. Specifically the bis-tetrahydrofuranylurethane moiety of DRV maintained interactions with the FLAP+ and ACT variants, whereas the 4-amino phenyl group lost more binding free energy with the protease in the FLAP+ and ACT complexes than in the wild-type protease, which could account for the majority of the loss in binding free energy. This suggested that replacement of the 4-amino phenyl group might generate new inhibitors less susceptible to the drug resistant mutations.Keywords
This publication has 60 references indexed in Scilit:
- Independent-Trajectories Thermodynamic-Integration Free-Energy Changes for Biomolecular Systems: Determinants of H5N1 Avian Influenza Virus Neuraminidase Inhibition by PeramivirJournal of Chemical Theory and Computation, 2009
- Evaluation of an inverse molecular design algorithm in a model binding siteProteins-Structure Function and Bioinformatics, 2009
- Computational design of antibody-affinity improvement beyond in vivo maturationNature Biotechnology, 2007
- Molecular Dynamics: Survey of Methods for Simulating the Activity of ProteinsChemical Reviews, 2006
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004
- The Many Roles of Computation in Drug DiscoveryScience, 2004
- A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculationsJournal of Computational Chemistry, 2003
- The Binding Energetics of First- and Second-Generation HIV-1 Protease Inhibitors: Implications for Drug DesignArchives of Biochemistry and Biophysics, 2001
- A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP modelThe Journal of Physical Chemistry, 1993
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993